Choice of End-points in Assessing the Efficacy of Post-discharge Prophylaxis for Venous Thromboembolism

• References

• 1 Dahl OE, Andreassen G, Aspelin T, Mathiesen P, Nyhus S, Abdelnoor M, Solhaug JH, Arnesen H. Prolonged thromboprophylaxis following hip replacement surgery – results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (fragmin^® ).. Thromb Haemost 1998; 77: 26-31.
• 2 Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.. Lancet 1996; 348: 224-8.
• 3 Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.. N Engl J Med 1996; 335: 696-700.
• 4 Agnelli G, Ranucci V, Veschi F, Rinonapoli E, Lupattelli L, Nenci GG. Clinical outcome of hip surgery patients with negative lower limb venography at discharge.. Thromb Haemost 1995; 74: 1042-4.
• 5 Anderson DR, Robinson KS, Gross M, Gent M. Compression ultrasound screening fails to reduce rate of symptomatic venous thromboembolic complications following total hip or knee arthroplasty.. Thromb Haemost 1998; Supplement: 583.
• 6 Ricotta S, Iorio A, Parise P, Nenci GG, Agnelli G. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography. An overview analysis.. Thromb Haemost 1996; 76: 887-92.